SD
Swati Dubey
University of California, Los Angeles, University of Helsinki, Indian Institute of Technology Roorkee, SGPGIMS, University of California Los Angeles, Chhatrapati Shahu Ji Maharaj University
0000-0003-1632-7940
About
A multidisciplinary researcher specializing in neuro-oncology and translational medicine, with a focus on molecular and metabolic vulnerabilities in high-grade gliomas. Seeking to leverage broad scientific expertise to bridge fundamental research with practical applications in clinical medicine.
Employment
-
University of California, Los Angeles Assistant Project Scientist2025 - Present
-
University of California, Los Angeles Postdoctoral Fellow2023 - 2025
-
University of California Los Angeles Postdoctoral Fellow2022 - 2023
-
Indian Veterinary Research Institute Senior Research Fellow2019 - 2021
-
Indian Institute of Technology Roorkee Senior Research Fellow2018 - 2019
-
University of Helsinki
Education
-
Indian Institute of Technology Roorkee Ph.D.2011 - 2017
-
SGPGIMS Junior Research Fellow (Enrolled for Doctoral Studies)2010 - 2011
-
Chhatrapati Shahu Ji Maharaj University M.Sc.2008 - 2010
-
Chhatrapati Shahu Ji Maharaj University B.Sc.2005 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (48)
- Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma Save
- Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD+ Metabolic Plasticity and NAMPT Inhibitor Sensitivity in Glioblastoma Save
- Abstracts Save
- Targeted Drug Discovery for High-grade Gliomas with Concurrent Nf1 and Atrx Loss Save
- Targeting NAD Metabolism as a Therapeutic Strategy for NF1- Associated High-Grade Gliomas Save
- RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implications Save
- 2025 101st AANP Annual Meeting Abstracts Save
- High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency Save
- Abstract 3106: Integrated in vitro and machine learning approaches for targeted drug screening in gliomas with concurrent NF1 and ATRX loss Save
- Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses Save